» Articles » PMID: 9806045

Impaired Tetanus-specific Cellular and Humoral Responses Following Tetanus Vaccination in Human Onchocerciasis: a Possible Role for Interleukin-10

Overview
Journal J Infect Dis
Date 1998 Nov 7
PMID 9806045
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Onchocerca volvulus infection has been associated with impaired cellular responses to parasite antigens, an impairment that may also extend to nonparasite antigens. To investigate the mechanism of this impaired immune response, the effect of concurrent O. volvulus infection on the immune response to tetanus toxoid (TT) following tetanus vaccination was studied. The proliferative, cytokine, and antibody response to TT of O. volvulus-infected subjects (n = 19) and comparable noninfected controls (n = 20) were studied before and 6 months after vaccination with TT. Following vaccination, antibody levels, proliferative responses, and levels of interferon-gamma were significantly greater in noninfected subjects (P < .05, .001, and .05, respectively); however, infected subjects produced interleukin-10, but noninfected controls did not (P < .001). These studies indicate that concurrent infection with O. volvulus can diminish the immune response to an unrelated antigen (TT) by a mechanism that is likely to involve interleukin-10.

Citing Articles

How does geographical diversity shape vaccine efficacy?.

Abavisani M, Ansari B, Ebadpour N, Sahebkar A Clin Exp Vaccine Res. 2024; 13(4):271-300.

PMID: 39525670 PMC: 11543789. DOI: 10.7774/cevr.2024.13.4.271.


Filariasis research - from basic research to drug development and novel diagnostics, over a decade of research at the Institute for Medical Microbiology, Immunology and Parasitology, Bonn, Germany.

Karunakaran I, Ritter M, Pfarr K, Klarmann-Schulz U, Debrah A, Debrah L Front Trop Dis. 2024; 4.

PMID: 38655130 PMC: 7615856. DOI: 10.3389/fitd.2023.1126173.


Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.

Barry H, Lhomme E, Surenaud M, Nouctara M, Robinson C, Bockstal V PLoS Negl Trop Dis. 2024; 18(4):e0011500.

PMID: 38603720 PMC: 11037528. DOI: 10.1371/journal.pntd.0011500.


Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.

Serwanga J, Ankunda V, Katende J, Baine C, Oluka G, Odoch G Front Immunol. 2024; 15:1348905.

PMID: 38357547 PMC: 10864610. DOI: 10.3389/fimmu.2024.1348905.


Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.

Desai P, Karl C, Ying B, Liang C, Garcia-Salum T, Santana A bioRxiv. 2024; .

PMID: 38293221 PMC: 10827110. DOI: 10.1101/2024.01.14.575588.